This inventor holds 1 USPTO granted patent. Top assignees: Fieldcure Co., Ltd., Korea University Research and Business Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Myongguen Yoon: Innovator in Electrotherapy
Introduction
Myongguen Yoon is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of electrotherapy through his innovative methods and systems. His work focuses on optimizing electrode array structures, which are crucial for effective electrotherapy treatments.
Latest Patents
Myongguen Yoon holds a patent for a "Method and system for optimizing electrode array structure in electrotherapy." This patent describes a method that involves obtaining information on a region-of-interest (ROI) and critical organs from input patient data. The process includes setting an overall shape and area of an electrode array based on this information, adjusting the area ratio of unit electrodes, and optimizing the electric field transmitted to the ROI and critical organs. The result is a customized electrode array structure that enhances the effectiveness of electrotherapy. He has 1 patent to his name.
Career Highlights
Throughout his career, Myongguen Yoon has worked with various organizations, including Fieldcure Co., Ltd. and Korea University Research and Business Foundation. His experience in these institutions has allowed him to develop and refine his innovative approaches to electrotherapy.
Collaborations
Myongguen Yoon has collaborated with Geon Oh, contributing to advancements in the field of electrotherapy. Their partnership has fostered the development of new techniques and methods that enhance patient care.
Conclusion
Myongguen Yoon's contributions to electrotherapy through his innovative patent and collaborative efforts highlight his role as a significant inventor in this field. His work continues to influence the development of effective treatment methods for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile